Arnold & Porter Recognized With Five 2020 LMG Life Sciences Awards for Antitrust, Patent, Life Sciences Work

Arnold & Porter's exceptional life sciences legal work was recognized a rare five times on September 23, 2020, at the eighth annual LMG Life Sciences Awards. Arnold & Porter won awards in two practice areas and two attorneys were recognized for their standout individual work this year. The firm also won "Patent Impact Case of the Year."

"Arnold & Porter is consistently recognized for its ability to handle client needs at every stage of a product's life cycle, so it is no surprise that the group has taken home awards across multiple practice areas. The firm remains a top contender when it comes to antitrust transactions and litigation, and continues to be on a hot streak of patent disputes that either produce new law, or are being eyed for it," LMG Life Sciences editor Chris Adams said of the firm's winners.

"These firm-level recognitions of course cannot be earned without the efforts of standout practitioners that make up the group. Practice co-chair Daniel Kracov proved again to be a market leader for FDA advice and regulatory strategy, while Kristen Riemenschneider represents the incoming generation of talent advising on life sciences deals," Adams said.

The firm was recognized in the following areas:

• Antitrust Firm of the Year;
• General Patent Litigation Firm of the Year;
• Patent Impact Case of the Year—Enzo Life Sciences v. Roche Molecular Systems et al.;
• Daniel Kracov—Regulatory Attorney of the Year: FDA Pharmaceutical; and
• Kristen Riemenschneider—US Rising Star: Financial & Corporate.

The firm's Antitrust practice group's work for Novartis and AbbVie this past year secured its spot as "Antitrust Firm of the Year" for the second year in a row, while Life Sciences & Healthcare Regulatory practice co-head Daniel Kracov was named "Regulatory Attorney of the Year: FDA Pharmaceutical" for the second time in three years. Both Kracov and Riemenschneider were recognized for the vital roles they played in the firm's work with clients responding to the COVID-19 pandemic through their work on various COVID-related vaccines.

Arnold & Porter's Intellectual Property practice nabbed both "General Patent Litigation Firm of the Year" and "Patent Impact Case of the Year." The recognition of "General Patent Litigation Firm of the Year" is a testament to the breadth and depth of the group and numerous high-profile victories secured for the firm's clients. The Enzo Life Sciences v. Roche Molecular Systems et al. litigation, selected as "Patent Impact Case of the Year," is an example of the group's recent success. The team included practice co-chair Matthew Wolf, who successfully argued the appeal securing affirmance of the summary judgment determination involving the complex and rapidly evolving doctrine of lack of enablement, as well as practice co-chair Jennifer Sklenar, Dr. Wallace Wu and Marty Koresawa.

The virtual awards celebrated "firms, individuals and companies behind the most innovative and challenging life sciences work of the past year." The awards are based on research conducted for the 2020 edition of LMG Life Sciences, the annual compendium that provides a guide to the life sciences industry and recommends outstanding legal professionals.